Camson Bio Technologies Limited announced unaudited standalone earnings results for the fourth quarter and full year for the year ended March 31, 2019. For the quarter, on standalone basis, the company reported revenue from operations of INR 5.878 million compared with negative revenue from operations of INR 5.091 million for the same period a year ago. Loss for the year was INR 113.005 million or INR 3.77 per basic and diluted share compared with INR 49.032 million or INR 1.63 per basic and diluted share for the same period a year ago. Total income was INR 14.109 million compared to negative total income of INR 7.478 million a year ago. For the full year, on standalone basis, the company reported revenue from operations of INR 49.762 million compared with INR 193.105 million for the same period a year ago. Loss for the year was INR 218.963 million or INR 7.30 per basic and diluted share compared with INR 112.171 million or INR 3.68 per basic and diluted share for the same period a year ago. Total income was INR 81.764 million compared to INR 206.078 million a year ago.